The reporter plasmid p(-905∆FP2)ColCAT were constructed using the technique of site-directed mutagenesis described by Ho et al. (1) . The polymerase chain reaction products were inserted into the p(-905)ColCAT vector after removing the fragment Pvu2-XbaI. In the p(-905∆FP2)ColCAT construct, the binding site for Sp1 and Sp3 extending from -129 to -110 bp had been converted from GGGGGCCGGGCC into GGGAACCTGGCC. Mobility shift assays confirmed that recombinant Sp1 does not bind oligonucleotides containing these mutated sequences. The reporter plasmid p(-126)Luc was constructed by subcloning the fragment -126 to +58 of the T-cell-specific MAL gene promoter into the promoterless plasmid p19Luc. This plasmid contains two consensus sites for nuclear factor Sp1 (2). In the reporter plasmid p∆SLuc, Sp1 cis-acting elements of the p(-126)Luc had been deleted (2) . All constructions and the orientation of the inserts were tested by restriction analysis and limited DNA sequencing by using an ABI PRISM 310 Genetic Analyzer (Perking Elmer Hispania. Madrid. Spain). 
